[
  {
    "ts": null,
    "headline": "Jim Cramer Shares Little Known Potential Catalyst For Abbott Laboratories (ABT)",
    "summary": "We recently published Jim Cramer Just Couldn’t Stop Talking About These 13 Stocks. Abbott Laboratories (NYSE:ABT) is one of the stocks Jim Cramer recently discussed. Abbott Laboratories (NYSE:ABT)’s shares have gained 16.7% year-to-date despite suffering from a major dip in July. The shares sank by 8.5% after the firm’s second-quarter earnings failed to satiate growth-hungry […]",
    "url": "https://finnhub.io/api/news?id=a99ab59d6b85de538554c9bb89a88cedab5e161f3f34b7d5beaf007d92fb1c39",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756665382,
      "headline": "Jim Cramer Shares Little Known Potential Catalyst For Abbott Laboratories (ABT)",
      "id": 136596197,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "We recently published Jim Cramer Just Couldn’t Stop Talking About These 13 Stocks. Abbott Laboratories (NYSE:ABT) is one of the stocks Jim Cramer recently discussed. Abbott Laboratories (NYSE:ABT)’s shares have gained 16.7% year-to-date despite suffering from a major dip in July. The shares sank by 8.5% after the firm’s second-quarter earnings failed to satiate growth-hungry […]",
      "url": "https://finnhub.io/api/news?id=a99ab59d6b85de538554c9bb89a88cedab5e161f3f34b7d5beaf007d92fb1c39"
    }
  },
  {
    "ts": null,
    "headline": "Abbott’s Possible Pokeno Acquisition Might Change the Case for Investing in Abbott Laboratories (ABT)",
    "summary": "In August 2025, it was reported that Abbott Laboratories was in discussions with Synlait Milk Limited to acquire the Pokeno manufacturing facility in New Zealand, a site specializing in plant-based milk products and recently flagged in Synlait’s business recovery review. This potential deal underscores Abbott’s ongoing diversification beyond core medical devices into nutritional and alternative product categories, as Synlait considers selling the facility amid efforts to address operational...",
    "url": "https://finnhub.io/api/news?id=e60fdfd0c03a5aa92115ae6211fee8f35cc76885b097531203d3ec69feed97bb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756638408,
      "headline": "Abbott’s Possible Pokeno Acquisition Might Change the Case for Investing in Abbott Laboratories (ABT)",
      "id": 136596198,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "In August 2025, it was reported that Abbott Laboratories was in discussions with Synlait Milk Limited to acquire the Pokeno manufacturing facility in New Zealand, a site specializing in plant-based milk products and recently flagged in Synlait’s business recovery review. This potential deal underscores Abbott’s ongoing diversification beyond core medical devices into nutritional and alternative product categories, as Synlait considers selling the facility amid efforts to address operational...",
      "url": "https://finnhub.io/api/news?id=e60fdfd0c03a5aa92115ae6211fee8f35cc76885b097531203d3ec69feed97bb"
    }
  }
]